490 BioTech
490 BioTech develops bioluminescent human cell lines to accelerate new drug discovery and testing.
Founded
2011490 BioTech develops bioluminescent human cell lines to accelerate new drug discovery and testing.
Founded in Knoxville, United States, 490 BioTech is a life sciences company dedicated to accelerating new drug discovery and testing. Their core mission is to enhance the efficiency and effectiveness of preclinical efficacy and toxicity testing through innovative bioluminescent human cell lines. These genetically engineered cells emit light to 'report' on biological events, providing real-time insights into cellular health and metabolic status. The company's products include continuously luminescent human cell models, assay kits for real-time cellular health monitoring, yeast-based environmental sensor kits, and custom bioluminescent solutions.
490 BioTech has garnered attention for its groundbreaking autobioluminescent technology, which does not require external activation to produce light. This innovation has attracted notable investors and partners in the biotechnology sector. The company's key achievements include securing patents for their bioluminescent cell lines and successfully integrating their technology into preclinical testing models. Overall, 490 BioTech's impact lies in its potential to significantly reduce the time and cost associated with drug development, thereby expediting the journey of new drugs from the lab to clinical trials.
Companies similar to 490 BioTech include ExpressCells, Light Bio, SymbioCellTech and Lumen Bioscience.
490 BioTech was founded in 2011.
490 BioTech's headquarters is located in Knoxville, TN, US.
490 BioTech's most recent funding round was for $50k (USD) in March 2021.
As of Mar 12, 2021, 490 BioTech has raised a total of $200k (USD).
490 BioTech has 6 employees as of Feb 4, 2024.
symbiocelltech.com
